The landscape of dementia prognosis has evolved dramatically with the appearance of complex biomarkers, like amyloid PET scans, tau imaging, and blood-primarily based checks which will detect Alzheimer's pathology a long time before indications emerge. While these technological advancements signify extraordinary progress in understanding neurodegenerative disorders, they've not dimini... https://pablof208enw6.csublogs.com/profile